This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Boryung Pharmaceutical Co., Ltd.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Sang Goo Shin: Innovator in Antihypertensive Pharmaceutical Composition
Introduction
Sang Goo Shin is a notable inventor based in South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antihypertensive medications. His work focuses on innovative compositions that aim to improve patient outcomes in hypertension management.
Latest Patents
Sang Goo Shin holds a patent for an antihypertensive pharmaceutical composition. This invention includes Fimasartan, which acts as an angiotensin II receptor blocker, and Amlodipine, a calcium channel blocker. The combination of these compounds is designed to effectively manage high blood pressure.
Career Highlights
Sang Goo Shin is currently associated with Boryung Pharmaceutical Co., Ltd. His role in the company has allowed him to engage in research and development of new pharmaceutical products. His expertise in antihypertensive therapies has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Sang Goo Shin has worked alongside talented colleagues, including Seung Ho Kim and Ji Han Kim. Their collaborative efforts contribute to the advancement of innovative pharmaceutical solutions.
Conclusion
Sang Goo Shin's work in antihypertensive pharmaceutical compositions showcases his dedication to improving healthcare through innovation. His contributions are vital in the ongoing battle against hypertension, and his collaborations further enhance the potential for future advancements in this field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile